BUSCOPAN

Solution for injection, 20mg/ml
RxActive license

Active substance (INN)

hyoscine butylbromide

Pharmaceutical form

Pharmaceutical formSolution for injection
Strength20mg/ml
PackagingUkupno 6 ampula sa po 1ml rastvora za injekciju u kartonskoj kutiji
ManufacturerBoehringer Ingelheim Espana S.A., Spain
Therapeutic groupAlimentary tract and metabolism (A03BB01)
Marketing authorization holderHEMOFARM A.D. VRŠAC P.J. PODGORICA
Authorization dateFebruary 6, 2025

Analogs in Montenegro

1

Other medicines with the same active substance

BUSCOPANOTC
Coated tablet, 10mgDelpharm Reims
Source: CInMED register